Eli Lilly and Company, along with Fluor staff at the Lebanon project construction site, hosted a blood drive earlier this ...

Machine learning applications in protein sciences have ushered in a new era for designing molecules in silico. Antibodies, which currently form the largest group of biologics in clinical use, stand to ...

The New York City-based start-up will identify new therapeutic targets by reconstructing immune histories, an approach the team terms as “forensic immunology.” Beck Brachman, PhD, CEO at ...

Background: The COMPASSION-15 trial demonstrated that cadonilimab plus chemotherapy (CAD-CHM) confers clinical benefits over placebo plus chemotherapy (PLA-CHM) as a first-line treatment for human ...

Once again, AbbVie dominates doctors’ ranking of makers of immunology meds. Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare ...

IRF5 program strengthens Kymera’s oral immunology pipeline with a complementary mechanism to expand into rheumatic and other autoimmune diseases with a potential best-in-class oral drug IRF5, a ...